Please assess the completion status of the following clinical trial:

Trial Title: To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients ≥40 and ≤ 80years of age~* Radiographic evidence of grade 2 or 3 osteoarthritis based on the Kellgren \& Lawrene radiographic entry criteria~* Stable osteoarthritis during 3 months~* Score of 100mm pain VAS ≤ 80mm at screening~* Score of 100mm pain VAS ≥ 50mm at baseline~* Written consent form voluntarily~Exclusion Criteria:~* Disease of spine or other Lower limb joints that could affect to evaluate the efficacy~* History of surgery or arthroscopy of the study joint within 6 months~* Trauma of study joint within 12 months~* Medication of constantly(more than 1 week) corticosteroid by oral within 3 months~* Medication of intra-articular injection within 3 months~* Diagnosed with psychical disorder, and taking medication~* History of upper gastrointestinal ulceration within 6 months~* History of upper gastrointestinal bleeding within 12 months~* Serum creatinine, ALT, AST, total bilirubin over UNL X 2.0 at screening test~* History of hypersensitivity to LAYLA, JOINS, or NSAIDs~* Participation in another clinical trials within 4 weeks~* Medication of constantly (more than 1 week) narcotic analgesics within 3 months~* Not consent about using effectual contraception method during trial~* Pregnant or lactating woman~* Investigator's judgment

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- LAYLA (Type: EXPERIMENTAL): Drug : LAYLA tablet/ bid
- JOINS (Type: ACTIVE_COMPARATOR): Drug : JOINS tablet/ tid

Based on this trial design, predict the completion outcome and termination type (if applicable).